Advances in sequencing technologies have enabled comprehensive genetic testing in kidney diseases, demonstrating substantial clinical value. Genetic testing improves diagnosis, prognosis, treatment selection, transplant risk assessment, living donor selection, reproductive counseling, and cascade testing. However, access remains limited worldwide. This session will review the clinical utility of genetic testing in nephrology, debate broad versus indication-based testing, and discuss strategies for integrating genetic testing into routine clinical care.
| Time | Session |
|---|---|
|
14:00
14:18
|
Clinical utility of genetic testing in nephrology
Becky Ma
Speaker
|
|
14:18
14:36
|
Genetic testing for CKD – Should we go broad or indication-based?
Roser Torra
Speaker
|
|
14:36
14:54
|
Implementation of genetic testing in nephrology – a global landscape
Andrew Mallett
Speaker
|
|
14:54
15:12
|
Mainstreaming clinical genetic testing in resource-limited settings
Mythri Shankar
Speaker
|
|
15:12
15:30
|
Q&A
|